Update in pathogenesis, diagnosis, and therapy of prolactinoma
N Fukuhara, M Nishiyama, Y Iwasaki - Cancers, 2022 - mdpi.com
Simple Summary This review updates recent advances in the pathogenesis, diagnosis, and
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …
Advances in the treatment of prolactinomas
MP Gillam, ME Molitch, G Lombardi… - Endocrine …, 2006 - academic.oup.com
Prolactinomas account for approximately 40% of all pituitary adenomas and are an
important cause of hypogonadism and infertility. The ultimate goal of therapy for …
important cause of hypogonadism and infertility. The ultimate goal of therapy for …
Prolactinoma
P Chanson, D Maiter - The pituitary, 2022 - Elsevier
Prolactinomas account for approximately 50% of all pituitary adenomas coming to medical
attention and are an important cause of hypogonadism and infertility. The ultimate goal of …
attention and are an important cause of hypogonadism and infertility. The ultimate goal of …
Epidemiology and management challenges in prolactinomas
Clinically relevant pituitary adenomas are present in about 1 per 1,000 of the general
population and prolactinomas are by far the most common clinical subtype of pituitary …
population and prolactinomas are by far the most common clinical subtype of pituitary …
Medical versus surgical treatment of prolactinomas: an analysis of treatment outcomes
MJ Rutkowski, MK Aghi - Expert Review of Endocrinology & …, 2018 - Taylor & Francis
Introduction: Prolactinomas are unique tumors that may go into both hormonal and
radiographic remission with dopamine agonist therapy or transsphenoidal surgery …
radiographic remission with dopamine agonist therapy or transsphenoidal surgery …
Prolactin and reproductive medicine
JRE Davis - Current Opinion in Obstetrics and Gynecology, 2004 - journals.lww.com
Prolactin and reproductive medicine : Current Opinion in Obstetrics and Gynecology Prolactin
and reproductive medicine : Current Opinion in Obstetrics and Gynecology Log in or Register …
and reproductive medicine : Current Opinion in Obstetrics and Gynecology Log in or Register …
Medical treatment of prolactinomas
A Colao, S Savastano - Nature Reviews Endocrinology, 2011 - nature.com
Prolactinomas, the most prevalent type of neuroendocrine disease, account for
approximately 40% of all pituitary adenomas. The most important clinical problems …
approximately 40% of all pituitary adenomas. The most important clinical problems …
Update on prolactinomas. Part 2: treatment and management strategies
The authors present an update on the various treatment modalities and discuss
management strategies for prolactinomas. Prolactinomas are the most common type of …
management strategies for prolactinomas. Prolactinomas are the most common type of …
Treatment strategies for dopamine agonist-resistant and aggressive prolactinomas: a comprehensive analysis of the literature
Despite most of the prolactinomas can be treated with endocrine therapy and/or surgery, a
significant percentage of these tumors can be resistant to endocrine treatments and/or recur …
significant percentage of these tumors can be resistant to endocrine treatments and/or recur …
Long-term management of prolactinomas
JA Schlechte - The Journal of Clinical Endocrinology & …, 2007 - academic.oup.com
Prolactinomas are a frequent cause of gonadal dysfunction and infertility, especially in
young women. The regulation of prolactin secretion and the efficacy of dopamine agonists in …
young women. The regulation of prolactin secretion and the efficacy of dopamine agonists in …